Zhang Xiang, Dunlow Ryan, Blackman Burchelle N, Swenson Rolf E
Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD, USA.
J Labelled Comp Radiopharm. 2018 May 15;61(5):427-437. doi: 10.1002/jlcr.3606. Epub 2018 Apr 17.
Traditional radiosynthetic optimization faces the challenges of high radiation exposure, cost, and inability to perform serial reactions due to tracer decay. To accelerate tracer development, we have developed a strategy to simulate radioactive F-syntheses by using tracer-level (nanomolar) non-radioactive F-reagents and LC-MS/MS analysis. The methodology was validated with fallypride synthesis under tracer-level F-conditions, which showed reproducible and comparable results with radiosynthesis, and proved the feasibility of this process. Using this approach, the synthesis of [ F]MDL100907 was optimized under F-conditions with greatly improved yield. The best conditions were successfully transferred to radiosynthesis. A radiochemical yield of 19% to 22% was achieved with the radiochemical purity >99% and the molar activity 38.8 to 53.6 GBq/ μmol (n = 3). The tracer-level F-approach provides a high-throughput and cost-effective process to optimize radiosynthesis with reduced radiation exposure. This new method allows medicinal and synthetic chemists to optimize radiolabeling conditions without the need to use radioactivity.
传统的放射性合成优化面临着高辐射暴露、成本高以及由于示踪剂衰变而无法进行连续反应等挑战。为了加速示踪剂的开发,我们开发了一种策略,通过使用示踪剂水平(纳摩尔)的非放射性氟试剂和液相色谱-串联质谱分析来模拟放射性氟合成。该方法在示踪剂水平的氟条件下通过法利哌德合成进行了验证,结果显示与放射性合成具有可重复性和可比性,并证明了该过程的可行性。使用这种方法,在氟条件下对[氟]MDL100907的合成进行了优化,产率大大提高。最佳条件成功地转移到了放射性合成中。放射化学产率达到19%至22%,放射化学纯度>99%,摩尔活度为38.8至53.6 GBq/μmol(n = 3)。示踪剂水平的氟方法提供了一种高通量且具有成本效益的过程,可在减少辐射暴露的情况下优化放射性合成。这种新方法使药物化学家和合成化学家无需使用放射性即可优化放射性标记条件。